The effect of combination therapy with intravitreal bevacizumab and topical timolol–dorzolamide eye drops on diabetic macular edema: a double-blind randomized controlled trial-Reference-Cited by-同舟云学术

The effect of combination therapy with intravitreal bevacizumab and topical timolol–dorzolamide eye drops on diabetic macular edema: a double-blind randomized controlled trial

Published:2024-02-20 Issue:1 Volume:44 Page:
ISSN:1573-2630
Container-title:International Ophthalmology
language:en
Short-container-title:Int Ophthalmol

Author:

Fekri Sahba,Rabiei Ali^ORCID,Hooshmandi Sadid,Nouri Hosein^ORCID,Abtahi Seyed-Hossein

Funder

Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10792-024-03005-z.pdf

Reference28 articles.

1. Miller K, Fortun JA (2018) Diabetic macular edema: current understanding, pharmacologic treatment options, and developing therapies. The Asia-Pacific J Ophthalmol 7(1):28–35

2. Tan GS et al (2017) Diabetic macular oedema. Lancet Diabetes Endocrinol 5(2):143–155

3. Romero-Aroca P et al (2016) Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J Diabetes Res 2016:2156273

4. Wong TY et al (2018) Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology 125(10):1608–1622

5. Schmidt-Erfurth U et al (2017) Guidelines for the management of diabetic macular edema by the european society of retina specialists (EURETINA). Ophthalmologica 237(4):185–222

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. O,S,Se-containing Biginelli products based on cyclic β-ketosulfone and their postfunctionalization;Beilstein Journal of Organic Chemistry;2024-08-27